HLB Life Science Co. Ltd. | Cash Flow
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
4,074
1,403
17,041
1,251
7,367
Depreciation, Depletion & Amortization
556
537
714
348
319
Other Funds
283
58
15
-
1,500
Funds from Operations
3,280
4,194
9,161
154
646
Changes in Working Capital
331
6,238
4,820
2,428
166
Net Operating Cash Flow
2,949
10,432
4,341
2,273
480
Capital Expenditures
81
542
688
1,300
307
Sale of Fixed Assets & Businesses
-
25
20
37
3,306
Purchase/Sale of Investments
869
924
6,084
23,745
345
Net Investing Cash Flow
1,401
972
6,449
25,004
2,419
Issuance/Reduction of Debt, Net
7,233
10,325
965
15,843
8,850
Net Financing Cash Flow
240
9,380
23,989
15,843
7,350
Net Change in Cash
1,787
80
13,200
11,434
9,289
Free Cash Flow
2,897
10,196
4,463
2,408
766
Net Assets from Acquisitions
-
7,845
-
-
-
Other Sources
2,133
9,158
2,094
2,133
2,750
Change in Capital Stock
7,190
1,002
24,969
-
-
Exchange Rate Effect
-
-
-
-
-
Other Uses
4,323
2,692
1,791
2,129
3,675
About HLB Life Science Co.
View Profile
